AACR 2024 Insights: "Mirvetuximab Soravtansine in Combination With Pembro for Patients With Microsatellite Stable Recurrent or Persistent Endometrial Cancer"

By ecancer FEATURING Rebecca Porter
By ecancer FEATURING Rebecca Porter
181 views
April 24, 2024
Comments 0
Login to view comments. Click here to Login